Tag: Post grant opposition

Patentee Rights During Pendency Of Post-Grant Opposition

Issues: In the case of Novartis AG & ANR v Natco Pharma Ltd, Swiss Pharma major Novartis has been granted patent for novel and inventive compound “Certinib” for treatment of non-small cell lung cancer. The suit patent was filed claiming priority since 2007, and was granted on 28th September, 2015. Novartis came across NOXALK (Natco … Continue reading Patentee Rights During Pendency Of Post-Grant Opposition

Read more »

Recent Change in America Invents Act

Congress passed the America Invents Act that makes major changes to the existing U.S. patent system.  President Obama signed the Act into law on September 16, 2011.  What does this mean for Indian Inventors and Research corporates who already filed Patents already or want to get a new patent file in US? The first impact is … Continue reading Recent Change in America Invents Act

Read more »